A Ten Year Serological Survey of Hepatitis A, B and C Viruses Infections in Nepal

Sawayama, Yasunori; Hayashi, Jun; Ariyama, Iwao; Furusyo, Norihiro; Kawasaki, Terukazu; Kawasaki, Mikio; Itoh, Kazuyoshi; Acharya, Gopal P.; Kashiwagi, Seizaburo

doi:10.2188/jea.9.350

Cited by 28 publications

(22 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…During the tenure of a month 2700 HIV patients were studied among which 100 of them had been infectious with mostly Hepatitis C virus and Hepatitis B virus [9][10][11][12].…”

Section: Introductionmentioning

confidence: 99%

Evidence of Hepatitis C Virus Infection and Associated Treatment in Nepal

Nepal¹

2016

J Mol Biomark Diagn

View full text Add to dashboard Cite

“…During the tenure of a month 2700 HIV patients were studied among which 100 of them had been infectious with mostly Hepatitis C virus and Hepatitis B virus [9][10][11][12].…”

Section: Introductionmentioning

confidence: 99%

Evidence of Hepatitis C Virus Infection and Associated Treatment in Nepal

Nepal¹

2016

J Mol Biomark Diagn

View full text Add to dashboard Cite

“…3 Different studies from Nepal showed that the sero-prevalence of HCV ranges from 0.35% to 1.73% in blood donors and healthy population with highest prevalence among injection drug users. [4][5][6][7][8] Six different HCV genotypes and multiple subtypes have been identified on the basis of molecular relatedness. …”

Section: Introductionmentioning

confidence: 99%

Clinical, Biochemical and Virological Profile of Patients with Chronic Hepatitis C Virus Infection - A Study from University Hospital in Nepal

Gurubacharya

Khadka²,

Shreshta³

et al. 2015

J Nobel Med Coll

View full text Add to dashboard Cite

Introduction: Hepatitis C virus (HCV) infection is a major public health challenge. It is a major cause for cirrhosis and hepatocellular carcinoma worldwide. Both the genotype and viral load of HCV determine the choice of therapy as well as outcome of therapy. The aim of this study was to evaluate clinical, biochemical and virological profile and association of HCV genotypes with viral load and liver biochemical profile. Material and Methods:This was descriptive observational study of chronic HCV infected patients who attended at the outpatient clinic of Department of Gastroenterology of TUTH, IOM from April 2013 to November 2014. During this study period 38 patients with chronic HCV infection were analyzed. Clinical profile, possible risk factors for transmission of HCV infection and liver biochemical profile were recorded. Virological profile included HCV viral load and HCV genotypes. Results:Out of 38 patients 34(89.5%) were male and 4(10.5%) were female. Injection drug use (IDU) was the most common mode for acquisition of HCV infection (55.3%). Genotype 3 was found in 21(55.26%) patients and genotype 1 was found in 17(44.74%) patients. There was no significant association between HCV genotypes and serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) level. And also there was no significant association between HCV viral load and different HCV genotypes. Conclusions:In our study HCV genotype 3 was the most prevalent genotype in patients with chronic HCV infection. Injection drug use was identified as most common identifiable risk factor for transmission of HCV infection. There was no significant association between different HCV genotypes and serum ALT, AST level and HCV viral load.

show abstract

“…HIV seroprevalence among blood donors in different regions of Nepal and Kathmandu Valley has been reported to range from 0.019% to 0.41% [4][5][6][7]. HBV seroprevalence has been reported to range from 0.3% to 4.0% in the general population of Nepal by various studies conducted from 1990 to 2003 [8][9][10][11][12][13]. HBsAg seroprevalence among Nepalese blood donors has been reported to range from 0.45 to 1.26% [4,[14][15][16][17].…”

Section: Introductionmentioning

confidence: 99%

“…HBsAg seroprevalence among Nepalese blood donors has been reported to range from 0.45 to 1.26% [4,[14][15][16][17]. HCV seroprevalence among Nepalese general population and blood donors has been reported to range from 0.1 to 1.7% [4,[10][11][12]16,[18][19][20][21]. Very little information is available on the prevalence of syphilis in the general population, although one of the focussed studies has reported it as 0.6% among Nepalese males [8].…”

Section: Introductionmentioning

confidence: 99%

Transfusion-transmissible infections among blood donors in Kathmandu, Nepal

Shrestha

Ghimire

Tiwari

et al. 2009

J Infect Dev Ctries

View full text Add to dashboard Cite

Background: Screening of transfusion-transmissible infections (TTIs) among blood donors can be a cost-effective approach to monitor the prevalence, distribution, and trends of the infections among healthy-looking individuals. The study aimed to determine the seroprevalence of four TTIs, human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) and syphilis, among blood donors in Kathmandu, Nepal. Methodology: A total of 21,716 units of blood were tested for the presence of anti-HIV 1/2 IgG/IgM, HBsAg, anti-HCV IgG/IgM, and antiTreponema pallidum IgG/IgM/IgA using commercial ELISA kits following standard protocols. Statistical analysis was performed using WinPepi Ver 3.8. Results: Seroprevalence of HIV, HBV (HBsAg), HCV and syphilis were observed to be 0.12% (95% CI = 0.08-0.18), 0.47% (95% CI = 0.39-0.57), 0.64% (95% CI = 0.54-0.75) and 0.48% (95% CI = 0.40-0.59) respectively. TTIs were dominant among male blood donors compared to female blood donors. Higher HCV seroprevalence among males compared to females was statistically significant. HIV prevalence was highest among blood donors in the age group 31 to 40 years (P > 0.5). HBV, HCV and syphilis prevalence was highest among blood donors 41 to 50 years age group, 21 to 30 years age group, and 51 to 60 years age group respectively (P < 0.05). HIV and HBV prevalence was relatively higher among first-time donors, whereas HCV and syphilis was relatively higher among the repeated donors (P > 0.05). Conclusions: It is of utmost importance to continue screening donated blood with highly sensitive and specific tests and to counsel donors who are positive to any of the above infections. It is absolutely necessary to avoid the transmission of infection from repeat donors.

show abstract

A Ten Year Serological Survey of Hepatitis A, B and C Viruses Infections in Nepal

Abstract: These results suggest that HAV has been endemic in Nepal for long time while not of HBV, and that HCV infection tends to be increased recently.

Cited by 28 publications

References 23 publications

Evidence of Hepatitis C Virus Infection and Associated Treatment in Nepal

Evidence of Hepatitis C Virus Infection and Associated Treatment in Nepal

Clinical, Biochemical and Virological Profile of Patients with Chronic Hepatitis C Virus Infection - A Study from University Hospital in Nepal

Transfusion-transmissible infections among blood donors in Kathmandu, Nepal

Contact Info

Product

Resources

About